Status:
NOT_YET_RECRUITING
A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
Lead Sponsor:
Fujian Cancer Hospital
Conditions:
Cervical Cancer
Radiotherapy
Eligibility:
FEMALE
20-85 years
Brief Summary
This study aims to help to screen out appropriate cases for consolidation therapy and more intensive follow up.
Detailed Description
Some cervical cancer patients experienced distant metastasis quickly after receiving complete radiotherapy and have a worse prognosis. However, there were few studies focused on these patients and wit...
Eligibility Criteria
Inclusion
- patients confirmed as cervical cancer by biopsies and treated with radiotherapy were initially enrolled
Exclusion
- (1) patients treated with surgery. (2) patient received incomplete treatment somewhere else. (3) patients with cancer history. (4) patients with pelvic surgery history. (5) patients without complete pre-treatment medical information. (6) patients with unfinished radical radiotherapy. (7) patients suffered from metastasis within 3 months after radiotherapy. (8) patients without complete 1-year follow-up materials
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06101966
Start Date
December 1 2023
End Date
December 1 2027
Last Update
October 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Cancer Hospital
Fuzhou, Fujian, China, 350014